News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025
Collage photo of Paolo Tarantino and Kelly Shanahan
Jun 30, 2025, 08:06

Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025

Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on X by Kelly Shanahan, Director of METAvivor Research and Support, adding:

“Nice to see our ADC toxicity review highlighted at MASCC25!”

Quoting Kelly Shanahan’s post:

“With ADCs, the same antibody or same payload in different combos can cause different toxicities.”

Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025

Title: Optimizing the safety of antibody–drug conjugates for patients with solid tumours

Authors: Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney

You can read the Full Article in Nature Reviews Clinical Oncology.

Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025

More posts featuring Paolo Tarantino and Kelly Shanahan.

ADCs Antibody drug conjugates cancer Kelly Shanahan MASCC25 OncoDaily Oncology Paolo Tarantino
Special Coverage
Blog
Jun 30, 2025, 08:06
Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025
Blog
Jun 30, 2025, 08:00
SIO to Host Pre-Conference Workshop on Music Therapy in Oncology Care
Blog
Jun 30, 2025, 07:59
Liz O’Riordan: The Terrifying Rise of Alternative Cancer Coaches - And The Nonsense They Told me to Do to Cure My Cancer
Blog
Jun 30, 2025, 07:47
Nataliya Kovalchuk Expresses Gratitude for Teaching Award Recognition
Insight
Jun 30, 2025, 07:38
Progress Made, But More Action Needed: João Breda's Message at the ELLOK 2nd Synergies Forum on Cancer Care
Blog
Jun 30, 2025, 07:38
AACR25 Session Recordings Available On-Demand Through October 31
Blog
Jun 30, 2025, 07:22
Petros Grivas: Grateful for Another Amazing Athens Meeting With Top Scientific and Social Agenda
Blog
Jun 30, 2025, 07:09
Katie Coleman Marks Four-Year Milestone After Surviving Rare Stage IV Cancer at 29
Insight
Jun 30, 2025, 06:57
Diego A. Díaz García Reflects on Nature Study Highlighting Challenges in Targeting Tumor-Infiltrating Tregs
Blog
Jun 30, 2025, 06:37
Lisa Lacasse: "This is the First Time I’ve Felt an Existential Crisis in Our Ability to Make Progress"
Dialogues
Jun 30, 2025, 06:33
Beyond the cancer diagnosis: Interview with Janet de Groot, hosted by Adrian Pogacian
Blog
Jun 30, 2025, 06:24
Stephen V. Liu Shares Phase II Data on First-Line Cisplatin, Irinotecan, and Durvalumab in SCLC